Science, Innovation and Hope: How to advance drug discovery for neurodegenerative diseases

“Translational gaps,” including interspecies differences between animal models and humans, create ample roadblocks during drug discovery. Our roundtable will highlight how innovators are trying to build a better bridge between preclinical and clinical success in neurodegenerative disease therapies by:

• Short-listing the highest-priority issues blocking effective treatments
• Spotlighting promising new strategies for drug discovery and therapeutic development
• Identifying transformations that will enable the drug development process to flow at “the speed of need.”

Insights provided by panelists:

• Rebecca Gilbert, MD, PhD | VP & CSO, American Parkinson Disease Foundation
• Jermaine Ross, PhD | VP & Head of Neuroscience, Immuneering
• Astrid Valles-Sanchez | Director, CNS Disease Biology - uniQure Amsterdam
• Shushant Jain, PhD | Director of Discovery Technology, Ncardia

Our session moderator:

• Andy Holt | Chief Commercial Officer, Ncardia